ATE226571T1 - Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen - Google Patents

Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen

Info

Publication number
ATE226571T1
ATE226571T1 AT00401268T AT00401268T ATE226571T1 AT E226571 T1 ATE226571 T1 AT E226571T1 AT 00401268 T AT00401268 T AT 00401268T AT 00401268 T AT00401268 T AT 00401268T AT E226571 T1 ATE226571 T1 AT E226571T1
Authority
AT
Austria
Prior art keywords
optionally substituted
retinol
rings
saturated
unsaturated
Prior art date
Application number
AT00401268T
Other languages
English (en)
Inventor
Remy Tuloup
Gilles Rubinstenn
Maria Dalko
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9546210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE226571(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE226571T1 publication Critical patent/ATE226571T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/12—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT00401268T 1999-06-01 2000-05-05 Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen ATE226571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9906872A FR2794457B1 (fr) 1999-06-01 1999-06-01 Derives carbonates de retinol, procede de preparation et utilisations

Publications (1)

Publication Number Publication Date
ATE226571T1 true ATE226571T1 (de) 2002-11-15

Family

ID=9546210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00401268T ATE226571T1 (de) 1999-06-01 2000-05-05 Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen

Country Status (8)

Country Link
US (2) US6331535B1 (de)
EP (1) EP1057809B1 (de)
JP (1) JP3576927B2 (de)
AT (1) ATE226571T1 (de)
CA (1) CA2309796C (de)
DE (1) DE60000635T2 (de)
ES (1) ES2185543T3 (de)
FR (1) FR2794457B1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811563B1 (fr) * 2000-07-13 2003-06-20 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive, et au moins un compose augmentant la synthese des glycosaminoglycanes
FR2811567B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
FR2819427B1 (fr) * 2001-01-18 2003-04-11 Oreal Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
DE10115840A1 (de) * 2001-03-30 2002-10-10 Basf Ag Retinylcarbonate in Kosmetika und Dermatika
US20030229158A1 (en) * 2001-09-28 2003-12-11 Chen Jen Chi Polymer composition and dosage forms comprising the same
FR2837704B1 (fr) * 2002-04-02 2005-01-14 Oreal Utilisation d'une sapogenine, ou un extrait naturel en contenant, pour le traitement des peaux seches oligoseborrheiques
US7008929B2 (en) * 2002-04-02 2006-03-07 L'oreal Sapogenin-based treatment
US7354956B2 (en) 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
FR2838344B1 (fr) * 2002-04-12 2005-06-17 Oreal Utilisation d'une sapogenine, ou d'un extrait naturel contenant, pour lisser les rides et ridules d'expression
EP1369411A1 (de) * 2002-06-07 2003-12-10 Cognis France S.A. Kosmetische und/oder pharmazeutische Zubereitungen mit Retinolestern
KR20040040792A (ko) * 2002-11-08 2004-05-13 주식회사 엘지생활건강 아미노산 또는 펩타이드가 결합된 레티놀 유도체 및 이를포함하는 피부노화 방지용 화장료 조성물
EP1861067A2 (de) * 2005-03-09 2007-12-05 Combe Incorporated Stabile mischemulsionen mit halbfesten dispersionen aus mindestens zwei separaten und eindeutig unterschiedlichen partikelgrössenbereichen
CA2600288A1 (en) * 2005-09-19 2007-04-12 Combe Incorporated Stable emulsion systems with high salt tolerance
JP2009523029A (ja) 2006-01-10 2009-06-18 コルゲート・パーモリブ・カンパニー 炎症の予防または軽減のために、細胞表面受容体を調節する方法
WO2010120275A2 (en) 2009-04-01 2010-10-21 Colgate-Palmolive Company Menthol-derivative compounds and use thereof as oral and systemic active agents
AR076041A1 (es) 2009-04-01 2011-05-11 Colgate Palmolive Co Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
AU2009343748B2 (en) 2009-04-01 2013-01-31 Colgate-Palmolive Company Anti-biofilm carbonate compounds for use in oral care compositions
TWI405565B (zh) 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗－骨質流失及抗－牙周附連喪失之功效
US11865197B2 (en) 2020-06-30 2024-01-09 L'oreal Cosmetic compositions having stabilized retinol
US11534381B2 (en) 2020-06-30 2022-12-27 L'oreal Cosmetic composition for improved penetration
US11819560B2 (en) 2020-08-31 2023-11-21 L'oreal Cosmetic compositions, kits thereof, and methods for making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0734371B1 (de) * 1993-12-15 2000-04-05 Avon Products, Inc. Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
JP3444326B2 (ja) * 1995-12-29 2003-09-08 ソニー株式会社 遠紫外線用ポジ型レジスト組成物

Also Published As

Publication number Publication date
FR2794457A1 (fr) 2000-12-08
JP2001019669A (ja) 2001-01-23
US20020019547A1 (en) 2002-02-14
EP1057809B1 (de) 2002-10-23
US6331535B1 (en) 2001-12-18
CA2309796C (fr) 2004-02-24
JP3576927B2 (ja) 2004-10-13
EP1057809A1 (de) 2000-12-06
FR2794457B1 (fr) 2001-08-10
DE60000635T2 (de) 2003-03-20
DE60000635D1 (de) 2002-11-28
ES2185543T3 (es) 2003-05-01
CA2309796A1 (fr) 2000-12-01
US6384025B2 (en) 2002-05-07

Similar Documents

Publication Publication Date Title
ATE226571T1 (de) Karbonatderivate von retinol, verfahren zu deren herstellung und verwendungen
ATE124405T1 (de) 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel.
ATE152092T1 (de) Salpetersäureester mit pharmazeutischer wirkung und verfahren zu deren herstellung
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
NO951775L (no) Nye 3,3-difenylpropylaminer, deres anvendelse og fremstilling
DE69332504D1 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
HUT67028A (en) Indole derivatives, pharmeceutical compositions comprising them and process for their production
PT97773A (pt) Processo para a preparacao de oxazolidinonas e de composicoes farmaceuticas que as contem
ES2173194T3 (es) Procedimiento de racemizacion utilizado para la preparacion de levobupivacaina y sus analogos.
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
BR1100061A (pt) Composto, processo para a preparação do mesmo, composição e uso dos mesmos
AR017172A1 (es) Compuestos derivados de 3,4-diariltiazolina-2-ona o 2-tiona un metodo para su preparacion y composiciones farmaceuticas que los comprenden
FR2688499B1 (fr) Procede de preparation de la beta-phenylisoserine et de ses analogues.
HUT62585A (en) Process for producing 6-amino-octahydro-indolizinetriole derivatives and phqrmaceutical compositions comprising same as active ingredient
ATE123773T1 (de) 1,3,5-triazin-2,4,6-tris- alkylaminocarbonsäureaminoester, diese enthaltende biozide mittel sowie verfahren zu ihrer herstellung.
DE69414695D1 (de) Glutaminsäure-derivate, ein verfahren zu ihrer herstellung und ihre verwendung zur steigerung des erinnerungsvermögens und der lernfähigkeit
EP0521393A3 (en) Diclofenac salt, a method for the preparation thereof and pharmaceutical compositions containing it
IT1254996B (it) Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
ATE116304T1 (de) Imidazol-derivate, verfahren zu deren herstellung und diese enthaltende zusammenstellungen.
DE68911616D1 (de) Piperazin-Derivate und Verfahren zu deren Herstellung.
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK0424504T3 (da) Nye 9alfa-hydroxy-3-oxo-4,24(25)-stigmastadien-26-syrederivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater med indhold deraf
PL338294A1 (en) Derivatives of streptogramins, method of obtaining them and compositions containing such derivatives
YU48094B (sh) Derivati fenoksietilamina i postupak za njihovo dobijanje
DE69018268T2 (de) Verfahren zur herstellung von geschützten aza-yperiten prodrugs.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1057809

Country of ref document: EP

REN Ceased due to non-payment of the annual fee